# Autism Spectrum Disorder

Use developmental surveillance and validated screening to trigger a comprehensive diagnostic assessment, then initiate individualized behavioral, communication, educational, and co-occurring-condition management without waiting for a single test to define care.

**Clinical question:** How should clinicians screen, diagnose, and initiate individualized management for autism spectrum disorder?

Updated: 2026-08-24T18:38:33.763294+00:00

## What matters in practice
- Treat a positive autism screen as a referral trigger, not a diagnosis; M-CHAT-R/F performance varies across populations despite pooled sensitivity of 78% and specificity of 98%. [3][8]
- Establish ASD clinically through developmental history, direct observation, and standardized assessment; ADOS-2 and ADI-R support, but do not replace, clinician judgment. [8][9][10][16]
- Select the ADOS-2 module by age and expressive language level; the assessment evaluates social communication, interaction, play or imagination, and restricted or repetitive behaviors. [9]
- Initiate needs-based behavioral, speech-language, occupational, and educational services after diagnostic concern or diagnosis; management targets functional impairment and co-occurring conditions rather than a medication treatment for core ASD features. [16][17][20]
- Assess epilepsy and developmental comorbidity when history indicates; epilepsy has been reported in approximately 5% to 46% of people with ASD. [23]

## Use screening to determine referral urgency

A screening result changes the next assessment step; it does not establish ASD.

Use developmental surveillance to identify persistent social-communication concerns, restricted or repetitive behaviors, developmental regression, language delay, adaptive impairment, or caregiver concern that warrants formal assessment. For toddlers, M-CHAT-R/F is the most commonly recommended screening instrument, but a negative screen should not override concerning surveillance findings. [3][8]

Refer children with a positive screen or clinically significant developmental concern for comprehensive ASD evaluation and concurrently connect them with developmental and therapeutic services appropriate to identified functional deficits. M-CHAT-R/F has pooled sensitivity of 78% and specificity of 98%, with substantial between-study variability; its predictive value therefore depends on the tested population and follow-up process. [3][8]

Do not use an ASD screening tool as a stand-alone diagnostic instrument. Diagnostic instruments also have imperfect operating characteristics: pooled estimates for ADOS were sensitivity 87% and specificity 75%, for ADI-R sensitivity 77% and specificity 68%, and for CARS sensitivity 89% and specificity 79%. [8]
- Escalate directly to comprehensive developmental assessment when developmental regression, substantial functional impairment, or a complex neurodevelopmental presentation is present, regardless of screening status. [16]
- Document the domains driving referral: communication, reciprocal social interaction, restricted or repetitive behavior, adaptive function, school participation, behavior, sleep, feeding, and safety. This establishes targets for intervention and longitudinal measurement. [16][17]

*Screening and diagnostic instruments answer different clinical questions. [8][9][10]*

| Instrument | Best clinical use | Interpretation and limitation |
| --- | --- | --- |
| M-CHAT-R/F | Toddler ASD screening and referral triage | Pooled sensitivity 78% and specificity 98%; variable performance means that clinical concern still warrants assessment after a negative result. [3][8] |
| ADOS-2 | Standardized direct observational assessment during diagnostic evaluation | Semi-structured assessment selected by age and expressive language; pooled sensitivity 87% and specificity 75%. [8][9] |
| ADI-R | Structured caregiver developmental history, particularly for complex assessment | Requires specific training and 1-2 hours; designed for use with ADOS-2 rather than as an isolated diagnostic test. [10] |
| CARS | Structured assessment to support diagnostic formulation | Pooled sensitivity 89% and specificity 79%; standardized scores require integration with the full clinical evaluation. [8] |

## Build the diagnosis from history, observation, and functional assessment

The diagnostic endpoint is a clinical formulation with an intervention-ready profile.

Conduct a comprehensive evaluation that integrates developmental history, direct observation, and standardized instruments such as ADOS-2 and ADI-R. The assessment should characterize social communication, reciprocal interaction, restricted or repetitive behavior, play or imagination, language, adaptive functioning, and the degree to which findings impair daily functioning. [9][10][16]

Use ADOS-2 as a standardized observational component when trained personnel are available. It is a semi-structured assessment with five modules selected according to age and expressive language ability; administration generally takes 45-60 minutes and includes activities intended to elicit diagnostic social-communication and restricted or repetitive behaviors. [9]

Use ADI-R when a structured informant history is needed to clarify early developmental symptoms, language and communication, mutual social interaction, stereotyped behaviors, and restricted interests. It requires trained administration and usually takes 1-2 hours; it was designed to complement direct observation rather than function as a solitary diagnostic procedure. [10]
- Translate diagnostic findings into measurable care targets: functional communication, adaptive skills, participation in education, disruptive behavior, emotional symptoms, sleep, feeding, and family burden. [16][17]
- Interpret standardized scores in context. Meta-analytic findings identify discordance between clinical judgment and threshold-based standardized testing, so neither a positive nor negative instrument score should substitute for the integrated clinical assessment. [8]

### When telehealth assessment is insufficient

Do not rely on telehealth alone to distinguish ASD from developmental language disorder when the differential remains unresolved. A systematic review found no telehealth tools that effectively differentiated these conditions in children; arrange in-person developmental assessment with direct observation when language disorder versus ASD remains a key decision. [11]

*Diagnostic assessment components and their decision value. [9][10][16]*

| Assessment component | Decision it informs | Next action |
| --- | --- | --- |
| Developmental and caregiver history | Establishes timing, persistence, developmental trajectory, communication profile, and repetitive-behavior history. [10][16] | Use the history to identify diagnostic complexity and targets for school and family supports. [16] |
| Direct observation | Documents current social interaction, communication, play or imagination, and restricted or repetitive behavior. [9] | Use a standardized observational assessment when available and integrate findings with functional impairment. [8][9] |
| Language and adaptive-function profile | Separates structural language, pragmatic communication, and daily-living support needs. [16] | Refer for speech-language and educational planning based on observed functional deficits. [16] |
| Behavioral and psychiatric assessment | Identifies challenging behavior, emotional symptoms, attention problems, and environmental triggers that may drive impairment. [17][20] | Use functional behavioral assessment when behavior targets are unclear or severe. [20] |

## Identify co-occurring neurologic, genetic, and functional conditions that change management

ASD care changes when regression, seizures, severe behavior, or a syndromic phenotype is present.

Elicit seizure-like events, episodes of unresponsiveness, convulsive events, and developmental plateau or regression. Epilepsy and ASD co-occur frequently; reported epilepsy prevalence in ASD ranges from approximately 5% to 46%. A concerning event history should prompt neurologic assessment directed at seizure classification and treatment rather than attribution of new behavioral change to ASD alone. [23]

Consider a syndromic or genetic branch when ASD coexists with intellectual disability, epilepsy, characteristic physical findings, or a family history suggestive of inherited neurodevelopmental disease. Fragile X syndrome is one established condition in which children should be evaluated for ASD and, if diagnostic criteria are met, may benefit from ASD interventions; medication sensitivity may require low starting doses and gradual titration when psychotropics are used. [20]

For severe aggression, destructive behavior, or persistent challenging behavior, first define antecedents, consequences, communication demands, sleep disruption, pain or medical contributors, and environmental mismatch through a functional behavioral assessment. The result should specify an intervention target and replacement skill rather than simply label behavior as an ASD symptom. [20][17]
- Assess for ADHD, anxiety or emotional difficulties, sleep disruption, feeding problems, sensory dysregulation, and educational barriers because each can independently limit participation and increase caregiver burden. [16][17][20]
- Use occupational therapy to identify accommodations and self-regulation approaches when hyperarousal or sensory issues interfere with function; desensitization or environmental accommodations may be components of the plan. [20]
- Refer serious aggressive or destructive behavior to pediatric psychiatry when safety risk or complexity exceeds the treating clinician's capacity for behavioral and medication management. [22]

*Comorbidity patterns that should redirect the assessment plan. [20][22][23]*

| Clinical pattern | Interpretation | Management branch |
| --- | --- | --- |
| Paroxysmal events, loss of awareness, convulsions, or regression | ASD and epilepsy commonly co-occur; reported epilepsy prevalence in ASD is approximately 5%-46%. [23] | Arrange neurologic assessment directed at seizure diagnosis and treatment. [23] |
| ASD with intellectual disability, epilepsy, physical findings, or suggestive family history | Raises concern for an underlying genetic neurodevelopmental disorder. [20][23] | Pursue syndrome-directed evaluation and coordinate ASD therapies with disorder-specific care. [20] |
| Aggression or destructive behavior | May reflect a functional behavior pattern, communication need, environmental trigger, or co-occurring psychiatric or medical problem. [20][22] | Perform functional behavioral assessment; involve pediatric psychiatry for serious aggression or destructive behavior. [20][22] |
| Hyperarousal or sensory-triggered functional impairment | Sensory and self-regulation difficulties may require individualized accommodations. [20] | Refer to occupational therapy for accommodation and desensitization strategies. [20] |

## Start individualized functional intervention and educational planning

Treat functional deficits and co-occurring conditions rather than pursuing a single ASD-directed therapy.

Create a written plan that specifies the impairment, intervention, setting, responsible discipline, measurable outcome, and reassessment interval. Core components commonly include behavioral intervention, speech-language therapy, occupational therapy when indicated, individualized educational support, and family training. [16][17][20]

Use applied behavior analysis or another structured behavioral intervention when the treatment target is a defined behavior, communication skill, social skill, adaptive skill, or participation barrier. ABA is individualized to behavioral, social, and adaptive strengths and weaknesses, typically delivered one-to-one by a board-certified behavior analyst, and uses measured progress to guide modification. [20][21]

For young children, early intensive behavioral intervention, Early Start Denver Model, intensive individualized intervention, cognitive behavioral therapy for relevant emotional difficulties, and parent-mediated intervention are among interventions supported in the reviewed literature. Select the modality by developmental level, target symptom, access, family capacity, and treatment response rather than assigning a uniform program. [17]
- Use parent-mediated intervention when caregiver coaching can improve the child's functioning or reduce challenging behavior; ensure parents receive specific, implementable skills rather than generic counseling. [17]
- Add speech-language therapy for functional communication targets and occupational therapy for sensory regulation, accommodations, and participation needs. [16][20]
- Coordinate an individualized education program or equivalent school-based plan around functional communication, adaptive skills, behavior supports, and classroom participation. [16][20]
- Track outcomes with the same functional targets used to justify therapy; change intensity or modality when measured progress is inadequate rather than continuing an unresponsive intervention indefinitely. [21]

### Medication and non-evidence-based treatments

Use psychotropic medication for a defined co-occurring target, in conjunction with behavioral and therapeutic services, rather than as treatment for ASD itself. For patients with fragile X syndrome or suspected medication sensitivity, start at low doses and titrate gradually to reduce adverse effects. [20]

Do not recommend glutathione for ASD treatment. FDA identified no data supporting effectiveness for ASD, and the small randomized study cited did not report efficacy outcomes. [1]

*Intervention selection should follow the functional target. [16][17][20][21]*

| Primary target | Intervention approach | Monitoring endpoint |
| --- | --- | --- |
| Communication impairment | Speech-language therapy plus behavioral or parent-mediated communication intervention. [16][17] | Functional communication across home, school, and community settings. [16] |
| Adaptive, social, or behavioral skills | Individualized ABA or intensive individualized behavioral intervention. [17][20][21] | Measured acquisition and generalization of the prespecified skill. [21] |
| Challenging behavior | Functional behavioral assessment followed by a targeted behavioral plan and caregiver implementation. [20] | Frequency, severity, antecedents, replacement behavior, and safety events. [20][21] |
| Sensory dysregulation or hyperarousal | Occupational therapy-directed accommodations, self-regulation strategies, and selected desensitization approaches. [20] | Participation, tolerance of environments, and functional independence. [20] |
| Emotional difficulty or anxiety-related impairment | Cognitive behavioral therapy when developmentally appropriate and accessible. [17] | Target emotional symptoms and impairment in daily participation. [17] |

## Monitor function, safety, and changing support needs

Follow-up should test whether the plan improves participation, not merely whether services were delivered.

At each follow-up, review the prespecified functional outcomes across home, school, and community settings: communication, adaptive skills, educational participation, behavior frequency and severity, sleep, feeding, emotional symptoms, and caregiver implementation burden. Maintain therapies that produce measurable benefit and revise goals when progress plateaus or developmental demands change. [16][21]

Reassess for newly apparent co-occurring conditions when there is a stepwise decline in function, emerging paroxysmal events, severe escalation of aggression, or a mismatch between intervention intensity and impairment. Epilepsy, ADHD, intellectual disability, and other neurodevelopmental conditions may co-occur and materially alter care planning. [23]

Coordinate prescribing clinicians, behavioral clinicians, speech-language pathologists, occupational therapists, school personnel, and family caregivers around a shared behavioral and functional plan. Multidisciplinary management is particularly important when medication is used for a co-occurring symptom target or when safety-related behavior persists. [20][22]
- Use functional behavioral reassessment when the behavior pattern changes, a replacement skill fails to generalize, or safety events continue despite an established plan. [20][21]
- Reevaluate school supports when communication, adaptive, behavioral, or cognitive demands exceed the current educational plan. [16]
- Escalate to subspecialty care for seizure concern, serious aggression or destructive behavior, suspected syndromic disease, or medication-management complexity. [20][22][23]

*Longitudinal review domains for ASD care. [16][20][21][23]*

| Domain | What to measure | Action when worsening or unchanged |
| --- | --- | --- |
| Communication and adaptive skills | Function in daily routines and across settings. [16] | Revise speech-language, behavioral, and educational targets. [16][21] |
| Challenging behavior and safety | Frequency, severity, antecedents, consequences, and injury or property-destruction events. [20][21] | Repeat functional assessment and intensify targeted behavioral planning; involve pediatric psychiatry for serious aggression or destructive behavior. [20][22] |
| Neurologic events | New paroxysmal events, altered awareness, convulsions, or regression. [23] | Arrange neurologic evaluation for possible epilepsy. [23] |
| Treatment response | Progress toward prespecified, measurable goals. [21] | Change intensity, setting, or intervention modality rather than continuing an ineffective program. [21] |

## References
1. IND Drug Development and Expanded Access (EA) — www.fda.gov — https://www.fda.gov/media/159042/download
2. Neonatal Docosahexaenoic Acid in Preterm Infants and ... — www.nejm.org — https://www.nejm.org/doi/full/10.1056/NEJMoa2206868
3. Sensitivity and Specificity of the Modified Checklist for ... — jamanetwork.com — https://jamanetwork.com/journals/jamapediatrics/fullarticle/2801663
4. Autism Spectrum Disorders — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/pdf/10.1002/j.2379-3988.2010.tb00063.x
5. Unpacking the prevalence — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/aur.3168
6. Autism Spectrum Disorder - Child and Adolescent ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/abs/10.1002/9781119487593.ch16
7. Autism spectrum disorder (ASD) and its perioperative ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1111/pan.12732
8. Screening and diagnostic tools for autism spectrum disorder: Systematic review and meta-analysis — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S180759322300159X
9. Autism Diagnostic Observation Schedule - an overview — www.sciencedirect.com — https://www.sciencedirect.com/topics/medicine-and-dentistry/autism-diagnostic-observation-schedule
10. Autism Diagnostic Interview Revised - an overview — www.sciencedirect.com — https://www.sciencedirect.com/topics/medicine-and-dentistry/autism-diagnostic-interview-revised
11. Telehealth diagnostic assessment for autism and developmental language disorders: A systematic review — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S0001691826009571
12. Blue Flash ERG PhNR Changes Associated with Poor Long ... — iovs.arvojournals.org — https://iovs.arvojournals.org/article.aspx?articleid=2188075
13. The Epidemiology of Congenital Cryptorchidism, Testicular Ascent and Orchiopexy — www.auajournals.org — https://www.auajournals.org/doi/abs/10.1097/01.ju.0000095793.04232.d8
14. Estimating fetal age: computer-assisted analysis of multiple ... — pubs.rsna.org — https://pubs.rsna.org/doi/10.1148/radiology.152.2.6739822
15. Infertility: Basic Research & Pathophysiology (MP01) — www.auajournals.org — https://www.auajournals.org/doi/pdf/10.1097/JU.0000000000003212
16. Nutritional management and autism spectrum disorder - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC11572612
17. Behavioral Interventions for Autism Spectrum Disorder - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC10774556
18. Saudi Expert Consensus-Based Autism Spectrum Disorder Statement: From Screening to Management - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC9496905
19. Efficacy of Interventions Based on Applied Behavior Analysis for Autism Spectrum Disorder: A Meta-Analysis — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC7265021
20. FMR1 Disorders - GeneReviews® - NCBI Bookshelf - NIH — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK1384
21. CHILDHOOD AND ADOLESCENCE DISORDERS - Nursing: Mental Health and Community Concepts - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK616977
22. Serine Deficiency Disorders - GeneReviews® - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK592681
23. Overlap Between Epilepsy and Neurodevelopmental Disorders: Insights from Clinical and Genetic Studies - Epilepsy - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK580619
24. Prevalence and Early Identification of Autism Spectrum .. ... — www.cdc.gov — https://www.cdc.gov/mmwr/volumes/74/ss/ss7402a1.htm

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.